Clinical Trials in Tennessee

Showing 17361-17380 of 20,239 trials

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT00604721

This phase II trial is studying selumetinib to see how well it works in treating patients with locally advanced or metastatic liver cancer. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more

National Cancer Institute (NCI)19 participantsStarted Nov 2007

Tampa, Florida, United States • Atlanta, Georgia, United States • Chapel Hill, North Carolina, United States +3 more locations

TERMINATEDEARLY Phase 129 miles

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

NCT00835679

This phase 0 trial is studying whether 2 weeks of cetuximab and dasatinib will change tumor cells in patients with colorectal cancer and liver metastases that can be removed by surgery. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more

National Cancer Institute (NCI)9 participantsStarted Dec 2009

Tampa, Florida, United States • Nashville, Tennessee, United States

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Find Trials by Condition in Tennessee

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

Study of Epratuzumab in Systemic Lupus Erythematosus

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

Global® AP™ Total Shoulder Arthroplasty

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

PHA-739358 for the Treatment of Multiple Myeloma

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept